CHRYSO
18.5.2021 14:02:13 CEST | Business Wire | Press release
CHRYSO, a leading player in the development of sustainable solutions in the construction industry, launches EnviroMix®, a global range of innovative products and services aimed at reducing and controlling the carbon footprint of concrete, dedicated to the ready-mix and precast concrete industries.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210518005573/en/
“The construction industry is accelerating its transformation to manage and reduce the environmental impact of its carbon footprint. CO2 footprint is a major challenge in the development of concrete formulations, coupled with the traditional properties of this material, and at the heart of our construction techniques (classes of strength and durability, workability, setting time, etc.)", states Frédéric Guimbal, Director of Concrete BU.
In order to pick up the pace of this low-carbon transition in the construction industry, the new range of tailor-made admixtures CHRYSO®EnviroMix
combines technical performance and carbon footprint reduction.
CHRYSO®EnviroMix
delivers a reduction in CO2
emissions of up to 50% and CHRYSO®EnviroMix ULC
(Ultra Low-Carbon) provides superior levels of performance as well as reduction of more than 50% in the carbon footprint. Products adapted to the specific performance requirements of ready-mixed concrete and precast applications will be deployed to support customers in the evolution of construction methods.
Customers can benefit from dedicated services such as EnviroMix®Impact, which allows the environmental impact calculation of a concrete mix design and to set up a formulation strategy adapted to their target. CHRYSO also offers a digital solution for real-time monitoring of CHRYSO®Maturix concretes. This solution allows the optimization of the rise in compressive strength at early age in the precast plant or on site.
Over the past 15 years, CHRYSO has bolstered its expertise in the field of low carbon impact concrete admixtures. Backed by a highly innovative technological portfolio, CHRYSO also benefits from specific know-how adapted to the chemistry of new low-carbon cements via its cement additives activity. CHRYSO solutions dedicated to this low carbon transformation are based on multiple scientific collaborations and industrial partnerships that reinforce the knowledge of these new binders, including geopolymers and Calcined Clay Cements (LC3 ).
"With this new comprehensive EnviroMix® product range, CHRYSO is creating new development levers for the construction industry by delivering solutions to produce the cements of tomorrow. It also offers the control of concrete admixtures using new binders, the formulation and real-time monitoring of low-carbon concretes on building sites while providing an accurate measurement of their CO2 impact. CHRYSO is supporting industry stakeholders in this low carbon revolution " declares Frédéric Guimbal, Concrete BU Director .
About CHRYSO: https://www.chryso.com/about-us/
View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005573/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 06:30:00 CET | Press release
Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan
VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 01:00:00 CET | Press release
Enabling Next-Generation High-Performance Automotive Camera Systems VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise
Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 22:30:00 CET | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 22:30:00 CET | Press release
Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to
Multi-Color Corporation Receives Court Approval of First Day Motions4.2.2026 21:30:00 CET | Press release
Obtains Interim Approval to Access $125 Million of DIP FinancingGlobal Operations and Services to Customers Continue in Normal Course Without Interruption During Restructuring Process; All Trade Vendors and Suppliers to be Paid in Full Multi-Color Corporation (“MCC” or the “Company”), a global leader in prime label solutions, today announced that it has received approval from the U.S. Bankruptcy Court for the District of New Jersey (the “Court”) for first day relief related to its prepackaged Chapter 11 filed on January 29, 2026. The approved relief affirms that the Company will operate in the normal course, pay all trade vendors and suppliers in full, and maintain a strong liquidity position during the restructuring. As part of this relief, the Court granted MCC immediate access to $125 million of $250 million in debtor-in-possession (“DIP”) new money financing, provided by certain holders of MCC’s secured first lien debt and its equity sponsor, CD&R. This funding will capitalize the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
